Literature DB >> 21371544

DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations.

Medha D Joshi1, Wendy W J Unger, Astrid J van Beelen, Sven C Bruijns, Manja Litjens, Louis van Bloois, Hakan Kalay, Yvette van Kooyk, Gert Storm.   

Abstract

Dendritic cells (DCs) are key antigen presenting cells that have the unique ability to present antigens on MHC molecules, which can lead to either priming or suppression of T cell mediated immune responses. C-type lectin receptors expressed by DCs are involved in antigen uptake and presentation through recognition of carbohydrate structures on antigens. Here we have explored the feasibility of modification of liposomes with glycans for targeting purposes to boost immune responses. The potential of targeting glycoliposomal constructs to the C-type lectin DC-SIGN on DCs was studied using either PEGylated or non-PEGylated liposomes. Our data demonstrate that formulation of the glycoliposomes as PEGylated negatively affected their potential to target to DCs.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21371544     DOI: 10.1016/j.ijpharm.2011.02.055

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

Review 1.  Applications of nanomaterials as vaccine adjuvants.

Authors:  Motao Zhu; Rongfu Wang; Guangjun Nie
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

2.  In situ Delivery of Antigen to DC-SIGN(+)CD14(+) Dermal Dendritic Cells Results in Enhanced CD8(+) T-Cell Responses.

Authors:  Cynthia M Fehres; Astrid J van Beelen; Sven C M Bruijns; Martino Ambrosini; Hakan Kalay; Louis van Bloois; Wendy W J Unger; Juan J Garcia-Vallejo; Gert Storm; Tanja D de Gruijl; Yvette van Kooyk
Journal:  J Invest Dermatol       Date:  2015-04-14       Impact factor: 8.551

3.  In situ Delivery of Tumor Antigen- and Adjuvant-Loaded Liposomes Boosts Antigen-Specific T-Cell Responses by Human Dermal Dendritic Cells.

Authors:  Martine A Boks; Sven C M Bruijns; Martino Ambrosini; Hakan Kalay; Louis van Bloois; Gert Storm; Tanja de Gruijl; Yvette van Kooyk
Journal:  J Invest Dermatol       Date:  2015-06-17       Impact factor: 8.551

Review 4.  Targeting human dendritic cells in situ to improve vaccines.

Authors:  Kartik Sehgal; Kavita M Dhodapkar; Madhav V Dhodapkar
Journal:  Immunol Lett       Date:  2014-07-27       Impact factor: 3.685

Review 5.  Biomimetic strategies for targeted nanoparticle delivery.

Authors:  Diana Dehaini; Ronnie H Fang; Liangfang Zhang
Journal:  Bioeng Transl Med       Date:  2016-05-27

Review 6.  Use of lectin-functionalized particles for oral immunotherapy.

Authors:  Susanne C Diesner; Xue-Yan Wang; Erika Jensen-Jarolim; Eva Untersmayr; Franz Gabor
Journal:  Ther Deliv       Date:  2012-02

7.  Targeting Dendritic Cells in vivo for Cancer Therapy.

Authors:  Irina Caminschi; Eugene Maraskovsky; William Ross Heath
Journal:  Front Immunol       Date:  2012-02-07       Impact factor: 7.561

8.  Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses.

Authors:  Dorian A Stolk; Aram de Haas; Jana Vree; Sanne Duinkerken; Joyce Lübbers; Rieneke van de Ven; Martino Ambrosini; Hakan Kalay; Sven Bruijns; Hans J van der Vliet; Tanja D de Gruijl; Yvette van Kooyk
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

Review 9.  Development and Characterization of Whey Protein-Based Nano-Delivery Systems: A Review.

Authors:  Ho-Kyung Ha; Scott A Rankin; Mee-Ryung Lee; Won-Jae Lee
Journal:  Molecules       Date:  2019-09-06       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.